Fibrinogen and risk of cardiovascular disease. The Framingham Study.
about
Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart StudyCoagulability in obstructive sleep apneaFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewJob strain and cardiovascular risk factors: a cross sectional study of employed Danish men and womenReplication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination SurveyPulmonary and hemostatic toxicity of multi-walled carbon nanotubes and zinc oxide nanoparticles after pulmonary exposure in Bmal1 knockout miceMultiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular diseaseFunctional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.Using family-based imputation in genome-wide association studies with large complex pedigrees: the Framingham Heart Study.The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments.Recent advances in ischaemic heart disease.A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease.Do HMG-CoA reductase inhibitors affect fibrinogen?Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study.Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score.Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health StudyDoes weight loss reduce plasma fibrinogen?A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo.Ethnic differences in risk markers for heart disease in Bradford and implications for preventive strategies.Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in NorwayBaseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogenPhysical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey.Expanded network of inflammatory markers of atherogenesis: where are we now?Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomesNovel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity.Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle interventionPharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention programGenetics of the Framingham Heart Study populationReducing adverse effects of immunosuppressive agents in kidney transplant recipients.Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease.Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.Composition of PM affects acute vascular inflammatory and coagulative markers - the RAPTES project.
P2860
Q21261432-95080800-E453-4ECC-96CC-F5ACA2B5B0DCQ26830210-ECFBB39D-103A-488C-A4C0-AB6BD7C5CF65Q28220294-A7E0A386-002E-42A0-A76F-4CAFB961E8CBQ28382945-263B6C73-CA87-4D96-956B-9D6530BA5D87Q28384226-BCC6E591-D1CE-430D-8A5C-B40421C72793Q28397769-67361448-27CC-4B72-83AB-F6F727B35554Q28661433-05F6D446-ECA1-47A0-91AF-5E2C26EC700BQ30352067-FDD0305F-C7DA-436B-988B-723D72BCBC93Q30413605-BA3017E1-2695-44EC-9149-E42433BFB9E5Q30423046-9C1D7BF8-A9DB-411D-A6A9-B354C64B134FQ30892742-33863227-ED5F-492C-A1CE-8FDB0B25CC1BQ30912640-E0D81831-909E-4EB3-A44A-F6E837D7FF42Q30998860-F0939DBA-2E3C-4753-8FBA-3C074B0DA63DQ32052986-C70D7473-7112-4E7B-9ADA-FC8D80724A3DQ32056571-09C046BA-86E6-42BC-AB29-AB27726A1230Q33168801-AAD0F7E4-E342-4DB0-BC4C-EA3368DD02DFQ33591268-415F5D37-47BF-43F5-95DB-696BE3DE3E5FQ33612628-39E4FAE5-9A33-4E8E-A8C6-3E9BCEA84C98Q33613250-FDC0A728-BB12-4848-916E-A872C63159B8Q33633625-D764A9FC-A9A2-433E-A1F1-77827F79C950Q33701658-43B49D1D-1293-4168-89F8-399A1DD64651Q33702516-7BE1C80A-4CCA-4F42-BF54-1AEBD326F0DDQ33702808-510D97CB-54A9-4218-B713-D62F10778CAFQ33703587-E3BD6340-37C5-4799-8CE3-C384CEAEE942Q33738532-E606D243-71CA-4156-B0E9-DF8E80275FCFQ33791968-71DB6C90-D720-4F0F-8861-2BE7E8464990Q33833259-54B5937F-0071-4CE2-994D-02CF0DDD0458Q33902971-A1290D29-5A66-4804-99A2-87BBA43A457CQ33911689-50AEB0D9-8D17-44B3-B532-D79AA059CB30Q34000383-9BF9B785-BA33-415B-B613-6DF50DF6E3FDQ34118083-775BC570-797D-4855-9220-18EBC3A78CF6Q34186113-125CFE6C-5767-4DF3-9A45-106716A7A443Q34373712-8B9C6F90-32BC-4C59-9BDD-C9545A9FE40EQ34457386-20D8DB33-BB52-41A2-B46E-5A8AA4D2B6C5Q34458072-927C3D04-B874-4F12-8D5A-57D9B641383DQ34547749-7A864A86-66D3-42A1-9EDE-62D50BD1A17FQ34568873-C4154050-1E0C-4E21-941E-F73318D88DFEQ34590848-F810E362-0556-4219-948E-8DD022A2DB1EQ34593955-316DA1E3-3A7B-4766-997D-396EC458BC31Q34630208-72643D27-7D3C-423B-BB00-1A038A06638C
P2860
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@en
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@nl
type
label
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@en
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@nl
prefLabel
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@en
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@nl
P2093
P1476
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
@en
P2093
R B D'Agostino
W B Kannel
W P Castelli
P304
P356
10.1001/JAMA.1987.03400090067035
P407
P577
1987-09-01T00:00:00Z